This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
MAXIMUS (MMS) Stock Drops 3.7% In Spite of Q3 Earnings Beat
by Zacks Equity Research
New COVID-19 response work aids MAXIMUS (MMS) Q3 fiscal 2021 performance.
Maximus (MMS) Surpasses Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Maximus (MMS) delivered earnings and revenue surprises of 48.21% and 13.31%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Maximus (MMS) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Maximus (MMS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here's Why You Should Hold MAXIMUS (MMS) in Your Portfolio
by Zacks Equity Research
MAXIMUS's (MMS) business process management expertise and ability to deliver cost-effective, efficient and high-scale solutions make it a lucrative partner to governments.
Strategic Acquisitions Aid MAXIMUS (MMS), High Debt Ails
by Zacks Equity Research
Strategic acquisitions complement MAXIMUS' (MMS) long-term organic growth strategy. However, high debt is a concern.
MAXIMUS (MMS) Falls 3.9% Despite Beating on Q2 Earnings
by Zacks Equity Research
New COVID-19 response work and increase in operating income drives MAXIMUS (MMS) second-quarter fiscal 2021 finacials.
Maximus (MMS) Surpasses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Maximus (MMS) delivered earnings and revenue surprises of 57.32% and 15.68%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
Maximus (MMS) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Maximus (MMS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
MAXIMUS (MMS) Stock Touches 52-Week High: What's Driving It?
by Zacks Equity Research
MAXIMUS (MMS) has been benefiting from encouraging yearly guidance, consistent better-than-expected revenue performance and shareholder-friendly moves.
Here's Why You Should Hold MAXIMUS (MMS) in Your Portfolio
by Zacks Equity Research
Strong balance sheet and financial flexibility aid MAXIMUS (MMS) stock. Meanwhile, global presence makes the company vulnerable to foreign currency exchange rate fluctuations.
MAXIMUS (MMS) Beats on Q1 Earnings, Raises 2021 Guidance
by Zacks Equity Research
MAXIMUS (MMS) first-quarter fiscal 2021 earnings and revenues increase year over year.
Maximus (MMS) Q1 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Maximus (MMS) delivered earnings and revenue surprises of 9.57% and 8.94%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
Maximus (MMS) to Report Q1 Earnings: What's in the Cards?
by Zacks Equity Research
Maximus' (MMS) first-quarter fiscal 2021 earnings and revenues are likely to have increased year over year.
Maximus (MMS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Maximus (MMS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Reasons to Retain MAXIMUS (MMS) Stock in Your Portfolio
by Zacks Equity Research
MAXIMUS (MMS) has a diversified portfolio with high operating profit margin, high cash conversion and access to a $400 million credit facility.
How Has MMS Performed 30 Days Post Earnings
by Zacks Equity Research
Maximus (MMS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
MAXIMUS (MMS) Stock Declines 2.1% Since Q4 Earnings Release
by Zacks Equity Research
MAXIMUS (MMS) fourth-quarter fiscal 2020 results benefit from new work and expansion of existing contracts.
Maximus (MMS) Q4 Earnings and Revenues Top Estimates
by Zacks Equity Research
Maximus (MMS) delivered earnings and revenue surprises of 12.09% and 6.67%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Maximus (MMS) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Maximus (MMS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Reasons to Retain MAXIMUS (MMS) Stock in Your Portfolio
by Zacks Equity Research
MAXIMUS (MMS) maintains solid relationships and strong reputation with governments and long-term contracts provide it with predictable recurring-revenue streams.
Should Value Investors Consider MAXIMUS (MMS) Stock Now?
by Zacks Equity Research
Let's see if MAXIMUS stock is a good choice for value-oriented investors right now from multiple angles.
Maximus Augments Contact Tracing Programs in Five States
by Zacks Equity Research
MAXIMUS's (MMS) financial performance is being boosted by its COVID-19-response work such as contact tracing and assistance with unemployment benefits.
Here's Why Investors Should Hold on to MAXIMUS (MMS) Stock
by Zacks Equity Research
Technology investments and strong capabilities in citizen engagement and complex program administration make MAXIMUS (MMS) a trusted partner to governments.
Why Is Maximus (MMS) Down 1.9% Since Last Earnings Report?
by Zacks Equity Research
Maximus (MMS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
MAXIMUS (MMS) Rides on Government Contracts, Debt Woe Stays
by Zacks Equity Research
With more than 40 years of experience, MAXIMUS (MMS) has grown to be a leading operator of government health and human-services programs globally.